Study on Allopregnanolone and Depression in Perimenopausal Women
Status:
Not yet recruiting
Trial end date:
2026-05-01
Target enrollment:
Participant gender:
Summary
This study aims to identify how the progesterone metabolite allopregnanolone affects behavior
and neurobiology that may underlie perimenopausal depression.